Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05394467Completed

Adipose Cellular Kinetics of Lipedema

Role: collaborator

NCT00833599Enrolling By Invitation

Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders

Role: collaborator

NCT03271034Not ApplicableCompleted

Effect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema

Role: collaborator

NCT03634462Not ApplicableCompleted

Complete Decongestive Therapy With Negative Pressure for Lipedema and Lymphedema Therapy

Role: collaborator

NCT02838277Unknown

Insight Into Subcutaneous Adipose Tissue Disorders

Role: collaborator

All 5 trials loaded